<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="26947">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02755935</url>
  </required_header>
  <id_info>
    <org_study_id>CAM5660</org_study_id>
    <nct_id>NCT02755935</nct_id>
  </id_info>
  <brief_title>CI532 - Early Experience Study</brief_title>
  <official_title>Implantation With the Cochlear NucleusÂ® CI532 Implant - Early Experience Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate performance outcomes in patients implanted with the Cochlear Nucleus CI532
      electrode array.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To compare speech perception and audiometric outcomes in patients implanted with the
      Cochlear Nucleus CI532 electrode array at 3 months postactivation with their best
      preoperative hearing status.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 2016</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Speech understanding (% correct) on AzBio sentences in quiet in the implanted ear</measure>
    <time_frame>pre implantation to 3 months postactivation of the sound processor</time_frame>
    <description>To determine if unilateral listening performance at 3 months post activation with the CI532 will be superior to the best aided unilateral preoperative condition for sentence perception in quiet.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Sensorineural Hearing Loss, Bilateral</condition>
  <arm_group>
    <arm_group_label>Implanted</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects who meet the specified inclusion criteria and are implanted with the CI532 cochlear implant</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cochlear Nucleus CI532</intervention_name>
    <description>cochlear implantation</description>
    <arm_group_label>Implanted</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Medical and audiological candidate for a CI532 cochlear implant per commercially
             approved, age appropriate, FDA indications

          -  Post-linguistically deafened

          -  Ability to complete age appropriate testing

        Exclusion Criteria:

          -  Previous cochlear implantation in the ear to be implanted

          -  Pre-linguistically deafened (onset of hearing loss at less than two years of age)

          -  Ossification or any other cochlear anomaly that might prevent complete insertion of
             the electrode array

          -  Diagnosis of retro-cochlear pathology

          -  Diagnosis of auditory neuropathy

          -  Unrealistic expectations on the part of the subject regarding the possible benefits,
             risks, and limitations that are inherent to the surgical procedure and use of the
             prosthetic device

          -  Unwillingness or inability to comply with all investigational requirements

          -  Additional cognitive handicaps that would prevent participation on all study
             requirements
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Months</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Lori ONeill, AuD</last_name>
    <phone>3035247180</phone>
    <email>loneill@cochlear.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shanell Laner</last_name>
    <phone>3032642493</phone>
    <email>slaner@cochlear.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NorthShore University</name>
      <address>
        <city>Skokie</city>
        <state>Illinois</state>
        <zip>60201</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mira Shiloach, MS</last_name>
      <phone>847-657-1750</phone>
      <email>mshiloach@northshore.org</email>
    </contact>
    <investigator>
      <last_name>Michael Shinners, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Iowa</name>
      <address>
        <city>Iowa City</city>
        <state>Iowa</state>
        <zip>52242</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diane Burke</last_name>
      <phone>319-356-2164</phone>
      <email>diane-burke@uiowa.edu</email>
    </contact>
    <investigator>
      <last_name>Bruce Gantz, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Camille Dunn-Johnson, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heidi Slager, AuD</last_name>
      <phone>734-998-8119</phone>
      <email>hkslager@med.umich.edu</email>
    </contact>
    <investigator>
      <last_name>Terry Zolan, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Hearing and Balance</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jacques Herzog, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Susan Rathgeb, AuD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Jacques Herzog, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Vanderbilt University Medical Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashudee Kirk, MS</last_name>
      <phone>615-936-2491</phone>
      <email>ashudee.kirk@vanderbilt.edu</email>
    </contact>
    <investigator>
      <last_name>Marc Bennett, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dallas Ear Institute</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75230</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bob Peters, MD</last_name>
      <phone>972-566-7600</phone>
    </contact>
    <investigator>
      <last_name>Robert Peters, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 6, 2017</lastchanged_date>
  <firstreceived_date>April 19, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
    <mesh_term>Hearing Loss, Bilateral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
